Cancer cachexia: Diagnosis, assessment, and treatment

被引:145
作者
Sadeghi, Mohammadamin [1 ,2 ,3 ]
Keshavarz-Fathi, Mahsa [2 ,3 ]
Baracos, Vickie [4 ]
Arends, Jann [5 ]
Mahmoudi, Maryam [2 ,6 ,7 ]
Rezaei, Nima [8 ,9 ,10 ]
机构
[1] USERN, MMIG, Tehran, Iran
[2] USERN, CIP, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[4] Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada
[5] Univ Freiburg, Fac Med, Dept Med 1, Med Ctr, Freiburg, Germany
[6] USERN, Dietitians & Nutr Experts Team DiNET, Tehran, Iran
[7] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran
[8] Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Tehran, Iran
[9] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[10] USERN, CIP, Sheffield, S Yorkshire, England
关键词
Cancer cachexia; Nutrition; Palliative medicine; Biomarker; Pharmacologic treatment; Nutritional treatment; Exercise; Psychological treatment; QUALITY-OF-LIFE; CELL LUNG-CANCER; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; MINI NUTRITIONAL ASSESSMENT; LEAN BODY-MASS; DIFFERENT ASSESSMENT CRITERIA; SUBJECTIVE GLOBAL ASSESSMENT; HYPOTHALAMIC NEUROPEPTIDE-Y; SKELETAL-MUSCLE MASS;
D O I
10.1016/j.critrevonc.2018.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life, responsiveness to chemotherapy, and survival in advanced cancer patients. Our understanding of cachexia has grown greatly in recent years and the roles of many tumor-derived and host-derived compounds have been elucidated as mediators of cancer cachexia. However, cancer cachexia remains an unmet medical need and attempts towards a standard treatment guideline have been unsuccessful. This review covers the diagnosis, assessment, and treatment of cancer cachexia; the elements impeding the formulation of a standard management guideline; and future directions of research for the improvement and standardization of current treatment procedures.
引用
收藏
页码:91 / 104
页数:14
相关论文
共 50 条
  • [41] Cachexia and pancreatic cancer: Are there treatment options?
    Mueller, Tara C.
    Burmeister, Marc A.
    Bachmann, Jeannine
    Martignoni, Marc E.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (28) : 9361 - 9373
  • [42] Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer
    Fujii, Hironori
    Makiyama, Akitaka
    Iihara, Hirotoshi
    Okumura, Naoki
    Yamamoto, Senri
    Imai, Takeharu
    Arakawa, Shinichiro
    Kobayashi, Ryo
    Tanaka, Yoshihiro
    Yoshida, Kazuhiro
    Suzuki, Akio
    ANTICANCER RESEARCH, 2020, 40 (12) : 7067 - 7075
  • [43] Differential Diagnosis of Cachexia and Refractory Cachexia and the Impact of Appropriate Nutritional Intervention for Cachexia on Survival in Terminal Cancer Patients
    Nakajima, Nobuhisa
    NUTRIENTS, 2021, 13 (03) : 1 - 8
  • [44] Update on Management of Cancer-Related Cachexia
    Lindsey J. Anderson
    Eliette D. Albrecht
    Jose M. Garcia
    Current Oncology Reports, 2017, 19
  • [45] Anamorelin for cancer cachexia
    Nishie, Kenichi
    Sato, Seiichi
    Hanaoka, Masayuki
    DRUGS OF TODAY, 2022, 58 (03) : 97 - 104
  • [46] Understanding the Role of Exercise in Cancer Cachexia Therapy
    Hardee, Justin P.
    Counts, Brittany R.
    Carson, James A.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2019, 13 (01) : 46 - 60
  • [47] Biomarkers of cancer cachexia
    Loumaye, Audrey
    Thissen, Jean-Paul
    CLINICAL BIOCHEMISTRY, 2017, 50 (18) : 1281 - 1288
  • [48] Endocrinopathies and cancer cachexia
    Dev, Rony
    Del Fabbro, Egidio
    Dalal, Shalini
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2019, 13 (04) : 286 - 291
  • [49] Cancer Cachexia: Its Mechanism and Clinical Significance
    Nishikawa, Hiroki
    Goto, Masahiro
    Fukunishi, Shinya
    Asai, Akira
    Nishiguchi, Shuhei
    Higuchi, Kazuhide
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [50] Progesterone therapy for the treatment of non-cancer cachexia: a systematic review
    Taylor, Joanne K.
    Pendleton, Neil
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2016, 6 (03) : 276 - 286